Resources Repository
-
DataWeb Portal 2024Human Development Reports: Data Portal
This data portal provides access to the United Nations Development Program’s Human Development Report data …
This data portal provides access to the United Nations Development Program’s Human Development Report data for the most current year and displays trends since 1990. The core aggregated metric presented in the HDR is the Human Development Index (HDI), a summary measure of average achievement in key dimensions of human development: a long and healthy life, being knowledgeable, and having a decent standard of living. Other indices include the Inequality-adjusted Human Development Index, the Gender…
Evidence Synthesis | Health Outcomes | Economics/Finance | Health Systems | Social Determinants | Climate/Environment | Education/Labor | Health/Medicine | Science/Technology | Global -
ReportPublication 2019Human Development Report 2019: Beyond Income, Beyond Averages, Beyond Today
This 2019 Human Development Report, published annually by the United Nations Development Programme (UNDP), explores …
This 2019 Human Development Report, published annually by the United Nations Development Programme (UNDP), explores the contemporary nature of inequalities in human development. Additional resources include digital versions and translations of the Report and the overview in more than 10 languages, an interactive web version of the Report, a set of background papers and think pieces commissioned for the Report, interactive data visualizations and databases of human development indicators, full explanations of the sources and…
Evidence Synthesis | Health Outcomes | Economics/Finance | Health Systems | Social Determinants | Climate/Environment | Education/Labor | Health/Medicine | Science/Technology | Global -
Teaching PackPublication, Teaching Resource 2022Teaching Pack: Extended Cost-Effectiveness Analysis
This teaching pack, curated by the Center for Health Decision Science, features videos introducing extended …
This teaching pack, curated by the Center for Health Decision Science, features videos introducing extended cost-effectiveness analysis (ECEA) and detailing how it is conducted, and assembles ECEA publications and teaching materials. In addition to the videos, this teaching pack includes a glossary and tutorial. Videos include: Video 1. Introduction to ECEA (~2 min) Video 2. Quantifying Health Benefits (~4 min) Video 3. Private Expenditures Averted (~3 min) Video 4. Financial Risk Protection (~5 min) Video 5.…
Costing Methods | Health Outcomes | Economics/Finance | Health Systems | Priority Setting/Ethics | Cost-Effectiveness Analysis | Social Determinants | Policy/Regulation | Health/Medicine | Global -
ReportPublication 2010Priorities for the National Vaccine Plan
The authors examine the complexities of the vaccine enterprise, a fundamental component of preventive medicine …
The authors examine the complexities of the vaccine enterprise, a fundamental component of preventive medicine and public health, from research and development of new vaccines to financing and reimbursement of immunization services. The current climate, socially, economically and politically, presents challenges and opportunities to the U.S. to strengthen the existing systems of developing, manufacturing, regulating, distributing, funding, and administering safe and effective vaccines for all people. The authors present recommendations for priority actions intended to…
Evidence Synthesis | Economics/Finance | Health Systems | Chronic Disease/Risk | Technology Assessment | Infectious Diseases | Policy/Regulation | Health/Medicine | Science/Technology | North America -
Resource PackWeb Portal, Teaching Resource 2017Resource Pack: Valuing Vaccines and GAVI
This resource pack on valuing vaccines and GAVI was curated by the Center for Health …
This resource pack on valuing vaccines and GAVI was curated by the Center for Health Decision Science to showcase existing information and analyses to motivate students, educators and others to pursue new applications of decision science methods to the public health challenge of vaccine preventable illnesses.
Calibration/Validation | Costing Methods | Economics/Finance | Health Systems | Preferences/Values | Priority Setting/Ethics | Mathematical Models | Dynamic Transmission | Benefit-Cost Analysis | Cost-Effectiveness Analysis | Infectious Diseases | Child/Nutrition | Global Governance | Government/Law | Health/Medicine | Science/Technology | Global | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Policy Translation | Quantitative Literacy -
ReportPublication 2017Underestimated Cost of the Opioid Crisis
This report on the opioid public health crisis was released by the White House Council …
This report on the opioid public health crisis was released by the White House Council on Economic Advisors (CEA) in November 2017. It corrects previous estimates of related costs by adding the value of the associated deaths. Earlier estimates focused on medical and other expenditures, while the new report also includes estimates of the value that individuals place on reducing their own risks of premature mortality. The report notes that, in 2015, over 33,000 Americans…
Costing Methods | Economics/Finance | Chronic Disease/Risk | Mental Health | Preferences/Values | Benefit-Cost Analysis | Policy/Regulation | Government/Law | Health/Medicine | North America -
ArticlePublication 2017Cost-Effectiveness of Testing and Treatment for Latent TB
Testing for and treating latent tuberculosis infection (LTBI) is among the main strategies to achieve …
Testing for and treating latent tuberculosis infection (LTBI) is among the main strategies to achieve TB elimination in the United States. This analysis estimated health outcomes, costs, and cost-effectiveness of LTBI testing and treatment among non-US born residents with and without medical comorbidities (e.g., diabetes, HIV infection, and end-stage renal disease). A decision analytic tree and Markov cohort simulation model was used to compare the following strategies: no testing, tuberculin skin test (TST), interferon gamma release assay…
Test Performance | Economics/Finance | Health Systems | Chronic Disease/Risk | State-Transition | Microsimulation | Cost-Effectiveness Analysis | Infectious Diseases | Health/Medicine | Global | North America -
BookPublication 2017What's In, What's Out: Designing Benefits for Universal Health Coverage
Many low- and middle-income countries now aspire to universal health coverage, where governments ensure that …
Many low- and middle-income countries now aspire to universal health coverage, where governments ensure that all people have access to the quality health services they need without risk of impoverishment. But for universal health coverage to become reality, the health services offered must be consistent with the funds available-and this implies tough everyday choices for policymakers. This publication argues that the creation of an explicit health benefits plan-a defined list of services that are and are…
Evidence Synthesis | Health Outcomes | Economics/Finance | Health Systems | Priority Setting/Ethics | Cost-Effectiveness Analysis | Technology Assessment | Policy/Regulation | Government/Law | Health/Medicine | Science/Technology | Global -
ArticlePublication 2017When Cost-Effective Interventions Are Unaffordable
Many health interventions deemed cost-effective are not affordable. Despite the importance of affordability to policymakers, …
Many health interventions deemed cost-effective are not affordable. Despite the importance of affordability to policymakers, little of the cost-effectiveness literature in global health addresses this issue. Budget impact analysis (BIA) describes an intervention's short-term costs and savings from the payer's perspective. This paper assesses the current use of budget impact analysis (BIA) and cost-effectiveness analysis (CEA) in health economic assessments conducted for low- and middle-income countries (LMICs). The authors recommend steps researchers and policymakers can…
Costing Methods | Economics/Finance | Health Systems | Chronic Disease/Risk | Priority Setting/Ethics | Cost-Effectiveness Analysis | Infectious Diseases | Government/Law | Health/Medicine | Science/Technology | Global